International
The Morning Science

What science found today

‹
 

Research

Malaria antibody protects infants but lowers immune response to R21 vaccine, trial finds

Medical Xpress ·

Malaria antibody protects infants but lowers immune response to R21 vaccine, trial finds

The Brief

  • A single intramuscular dose of the experimental malaria monoclonal antibody L9LS safely gave infants strong protection during Mali's six-month malaria season.
  • The antibody may interfere with the immune response to the R21 malaria vaccine.
  • This potential interference puts plans to pursue development of L9LS in question.

Why it matters

Monoclonal antibodies could offer a complementary tool against malaria in infants, but if they blunt vaccine responses, combined immunization strategies would need to be reconsidered.

Who’s affected

  • malaria researchers and clinicians
  • public health planners in malaria-endemic regions

A single intramuscular dose of an experimental malaria monoclonal antibody safely provided infants with strong protection during Mali's six-month malaria season. However, potential interference with the R21 malaria vaccine is putting plans to pursue development of L9LS for this…

Timeline

  1. Trial results reported showing infant protection and possible interference with R21 vaccine response

  2. Medical Xpress - latest medical and health news stories

    Malaria antibody protects infants but lowers immune response to R21 vaccine, trial finds

How do you feel about this?

0 Comments

    Malaria antibody protects infants but lowers immune response to R21 vaccine, trial finds – The Morning Science